REGULUS THERAPEUTICS INC (RGLS)

US75915K3095 - Common Stock

1.56  -0.02 (-1.27%)

After market: 1.56 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.0010.01M
Operating Expenses
44.60M31.11M28.24M27.82M24.16M
Research and Development
31.20M21.01M18.31M17.35M14.90M
Selling, General, and Administrative Expenses
13.14M9.96M9.83M10.02M8.81M
Operating Income
-44.60M-31.11M-28.24M-27.82M-14.16M
Interest Income/Expense
2.97M1.07M-80.00K10.00K-1.58M
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-41.63M-30.04M-28.32M-27.81M-15.73M
Income Tax
N/A1.00K0.000.000.00
Net Income
-41.63M-30.04M-28.32M-27.81M-15.73M
EBITDA
-44.26M-30.88M-28.12M-27.36M-13.69M
 
Per Share Data
EPS Diluted Total Ops
-1.08-1.58-1.86-3.24-4.50
Non GAAP EPS
-1.07-1.59-1.90-3.30-5.50
 
Statistics
Profit Margin
N/AN/AN/AN/A-157.14%
Operating Profit Margin
N/AN/AN/AN/A-141.46%

All data in USD

Charts